|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash Dividend Payment Amount and Rates
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash Dividend Payment Time Interval
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount and Rate of Cash Dividend Stock Dividend Payment
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Explanations
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
As a result of the evaluation of Profit Distribution Policy of our Company which has been approved by the shareholders at the General Assembly Meeting dated March 28, 2013 and the Capital Markets Law and the Article 33 of the Articles of Association along with considering the long-term strategies, investment, cash and financing policies of our Company and the long-term interests of our Company and the shareholders; it has been decided to submit for the approval of our shareholders about the following matters for the 2019 fiscal year, at the Ordinary General Assembly Meeting which is expected to take place on March 30, 2020, dividend distribution in cash by gross TRY 135,000,000 out of the distributable net profit for 2019 in accordance with the Profit Distribution Proposal Table attached, to allocate the remaining balance as extraordinary reserves/ previous year profits, and to give authorization to the Board of Directors for determining the date of the dividend distribution.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DIVIDEND DISTRIBUTION TABLE
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ÜLKER BİSKÜVİ SANAYİ A.Ş. 01.01.2019/31.12.2019 Period Dividend Payment Table (TL)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividend Payment Rates Table
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividend Rate Table Explanations
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
As a result of the evaluation of Profit Distribution Policy of our Company which has been approved by the shareholders at the General Assembly Meeting dated March 28, 2013 and the Capital Markets Law and the Article 33 of the Articles of Association along with considering the long-term strategies, investment, cash and financing policies of our Company and the long-term interests of our Company and the shareholders; it has been decided to submit for the approval of our shareholders about the following matters for the 2019 fiscal year, at the Ordinary General Assembly Meeting which is expected to take place on March 30, 2020, dividend distribution in cash by gross TRY 135,000,000 out of the distributable net profit for 2019 in accordance with the Profit Distribution Proposal Table attached, to allocate the remaining balance as extraordinary reserves/ previous year profits, and to give authorization to the Board of Directors for determining the date of the dividend distribution. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.